Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Acupuncture, Taste Disorders, Dysgeusia, Chemotherapy, Cancer

In brief

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Key facts

Study ID

NCT02304913

Run by

Universität Duisburg-Essen

People needed

75

Starts

2015-01-01

Expected to finish

2027-12-31

Last updated by the study team

2026-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Initial treatment with platinum-containing or taxane-based CTX (regardless of the the length of the CTX cycle)
• Senological, gynecological or internistic tumors
• Phantogeusia (on average ≥4 NRS)
• Willingness to participate in the study and written informed consent

You may not qualify if…

• Severe stomatitis
• Dysgeusia before the CTX based on neurological diseases, diabetes, or the ingestion of drugs with taste disorders as side effects
• Leucopenia/neutropenia
• Intake of anticoagulants
• Smoking
• Severe physical or mental comorbidity (due to which the patient is unable to participate in the study)
• Participation in other CAM treatments within the integrative oncology care
• Participation in other studies on the effectiveness of interventions for oral complications

Where it is running

• Universitätsklinikum Mannheim, Internistische Onkologie — Mannheim, Germany (enrolling)
• Department of Gynecology & Gynecologic Oncology, Evang. Kliniken Essen-Mitte — Essen, North Rhine-Westphalia, Germany
• Robert Bosch Krankenhaus Stuttgart — Stuttgart, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.